1. Home
  2. PRTC vs NEON Comparison

PRTC vs NEON Comparison

Compare PRTC & NEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTC
  • NEON
  • Stock Information
  • Founded
  • PRTC 2015
  • NEON 1997
  • Country
  • PRTC United States
  • NEON Sweden
  • Employees
  • PRTC N/A
  • NEON N/A
  • Industry
  • PRTC Biotechnology: Pharmaceutical Preparations
  • NEON Industrial Machinery/Components
  • Sector
  • PRTC Health Care
  • NEON Technology
  • Exchange
  • PRTC Nasdaq
  • NEON Nasdaq
  • Market Cap
  • PRTC 413.5M
  • NEON 428.0M
  • IPO Year
  • PRTC N/A
  • NEON 2007
  • Fundamental
  • Price
  • PRTC $19.07
  • NEON $27.34
  • Analyst Decision
  • PRTC Buy
  • NEON Strong Buy
  • Analyst Count
  • PRTC 1
  • NEON 1
  • Target Price
  • PRTC $45.00
  • NEON $16.50
  • AVG Volume (30 Days)
  • PRTC 3.4K
  • NEON 452.3K
  • Earning Date
  • PRTC 08-27-2025
  • NEON 08-07-2025
  • Dividend Yield
  • PRTC N/A
  • NEON N/A
  • EPS Growth
  • PRTC N/A
  • NEON N/A
  • EPS
  • PRTC 0.21
  • NEON N/A
  • Revenue
  • PRTC $4,828,000.00
  • NEON $2,807,000.00
  • Revenue This Year
  • PRTC $35.98
  • NEON N/A
  • Revenue Next Year
  • PRTC $115.38
  • NEON $39.01
  • P/E Ratio
  • PRTC $8.64
  • NEON N/A
  • Revenue Growth
  • PRTC 44.98
  • NEON N/A
  • 52 Week Low
  • PRTC $13.30
  • NEON $2.22
  • 52 Week High
  • PRTC $25.00
  • NEON $29.90
  • Technical
  • Relative Strength Index (RSI)
  • PRTC 57.26
  • NEON 61.10
  • Support Level
  • PRTC $18.16
  • NEON $26.80
  • Resistance Level
  • PRTC $19.60
  • NEON $29.90
  • Average True Range (ATR)
  • PRTC 0.43
  • NEON 2.03
  • MACD
  • PRTC 0.10
  • NEON -0.31
  • Stochastic Oscillator
  • PRTC 69.77
  • NEON 57.48

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

About NEON Neonode Inc.

Neonode Inc provides optical sensing solutions for contactless touch, and gesture sensing and also provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. It markets and sells its solutions to customers in many different markets and segments including, but not limited to, office equipment, automotive, industrial automation, medical, military, and avionics. The company geographically operates in the United States, Japan, South Korea, Germany, Sweden, China, and other regions. A majority of its revenue is generated from Japan.

Share on Social Networks: